Screening for RB1 mutations in tumor tissue using denaturing high performance liquid chromatography, multiplex ligation-dependent probe amplification, and loss of heterozygosity analysis

Pediatric and Developmental Pathology

Volumn 9, Issue 1, 2006, Pages 31-37

  Sellner, Loryn N ^a   Edkins, Edward ^a,b   Smith, Nicholas ^a  

^a PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^b EDITH COWAN UNIVERSITY   (Australia)

Author keywords

Duplication; Germline; LOH; MLPA; Mutation; Retinoblastoma

Indexed keywords

ARTICLE; CHROMOSOME DELETION; CLINICAL ARTICLE; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; EXON; GENE DELETION; GENE DUPLICATION; GENE INSERTION; GENE MUTATION; GENETIC SCREENING; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; INFANCY; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR BIOLOGY; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MULTIPLEX POLYMERASE CHAIN REACTION; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; RETINA TUMOR; RETINOBLASTOMA; RISK ASSESSMENT; TUMOR SUPPRESSOR GENE; UNIPARENTAL DISOMY; CHEMISTRY; CHILD; DNA DENATURATION; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFANT; METABOLISM; METHODOLOGY; NUCLEIC ACID AMPLIFICATION; PATHOLOGY; PRESCHOOL CHILD;

DNA; MICROSATELLITE DNA; PRIMER DNA; RETINOBLASTOMA PROTEIN;

CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; DNA, NEOPLASM; GENETIC SCREENING; HUMANS; INFANT; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; NUCLEIC ACID DENATURATION; RETINAL NEOPLASMS; RETINOBLASTOMA; RETINOBLASTOMA PROTEIN;

EID: 33746206344     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/07-05-0078.1     Document Type: Article

References (13)

1. Vogel F. Genetics of retinoblastoma. Hum Genet 1979;52:1-54.
2. Richter S, Vandezande K, Chen N, et al. Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. Am J Hum Genet 2003;72:253-269.
3. Lohmann DR, Brandt B, Hopping W, Passarge E, Horsthemke B. The spectrum of RB1 germ-line mutations in hereditary retinoblastoma. Am J Hum Genet 1996;58:940-949.
4. Lohmann D, Scheffer H, Gaille B. Best Practice Guidelines for Molecular Analysis of Retinoblastoma. 2002. Available at: http://wwwl.emqn.org/ Best_Practice/Guidelines.html
5. Houdayer C, Gauthier-Villars M, Lauge A, et al. Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSF. Hum Mutat 2004;23:193-202.
6. Choy KW, Pang CP, Yu CBO, et al. Loss of heterozygosity and mutations are the major mechanisms of RB1 gene inactivation in Chinese with sporadic retinoblastoma. Hum Mutat 2002.
7. Zhu X, Dunn JM, Goddard AD, et al. Mechanisms of loss of heterozygosity in retinoblastoma. Cytogenet Cell Genet 1992;59:248-252.
8. Hagstrom SA, Dryja TP. Mitotic recombination map of 13cen-13q14 derived from an investigation of loss of heterozygosity in retinoblastomas. Proc Natl Acad Sci U S A 1999;96:2952-2957.
9. Lohmann DR. RB1 gene mutations in retinoblastoma. Hum Mutat 1999;14:283-288.
10. Jakubowska A, Zajaczek S, Haus O, et al. Novel RB1 gene constitutional mutations found in Polish patients with familial and/or bilateral retinoblastoma. Hum Mutat 2001;18(5):459.
11. Ohtani-Fujita N, Dryja TP, Rapaport JM, et al. Hypermethylation in the retinoblastoma gene is associated with unilateral, sporadic retinblastoma Cancer Genet Cytogenet 1997;98:43-49.
12. Moll AC, Imhof SM, Cruysberg JRM, Schouten-van Meeteren AYN, Boers M, van Leeuwen FE. Incidence of retinoblastoma in children born after in-vitro fertilisation. Lancet 2003;361:309-310.
13. Gosden R, Trasler J, Lucifero D, Faddy M. Rare congenital disorders, imprinted genes, and assisted reproductive technology. Lancet 2003;361:1975-1977.